Researchers find that microRNA molecule inhibits production of insulin

July 10, 2007
Researchers find that microRNA molecule inhibits production of insulin

The body's ability to produce insulin could be enhanced through targeting a newly discovered molecule, helping to fight diabetes, according to research published today in the Journal of Biological Chemistry.

The molecule, described by researchers from Imperial College London and INSERM U145 and EMI 0363 in France, is a microRNA known as miR124. The researchers found that miR124 inhibits the production of insulin in the pancreas. It does this by controlling how several genes are expressed in the body’s beta cells, which secrete insulin.

Insulin is the principal hormone that regulates the uptake of glucose and if the body produces insufficient insulin this can cause diabetes.

The researchers believe that if drugs could be developed to suppress the action of miR124, and related microRNAs, in those with diabetes, this could enable more insulin to be produced, helping to combat the condition.

DNA encodes proteins via an intermediate messenger known as RNA, which is then 'translated' to create different proteins. MicroRNAs bind to and inhibit the translation of selected messenger RNAs. They block the synthesis of the encoded proteins and this interferes with processes carried out by cells.

Synthetic molecules known as antagomirs can inactivate microRNAs and scientists are hopeful that they might one day be able to harness their properties to switch off selected microRNAs, including miR124. The researchers are also keen to understand whether variations, or "polymorphisms", exist in the gene that encodes miR124, predisposing certain individuals to diabetes.

Professor Guy Rutter , from the Division of Medicine at Imperial College London and one of the authors of the research, said: "Scientists only discovered the importance of microRNAs a few years ago. Discovering that this particular microRNA plays a fundamental role in the control of insulin production is exciting, and may allow us to develop new tools to treat diabetes. Such findings may be useful in the fight against a disease which affects more than 5 % of the population and whose incidence is growing yearly."

This research was funded by The Wellcome Trust, the Medical Research Council and INSERM.

Source: Imperial College London

Explore further: Study links developmental and lipid handling pathways in C. elegans

Related Stories

A boost in microRNA may protect against obesity and diabetes

March 15, 2016

Obesity, which is associated with low-grade inflammation, is an important contributor in the development of diabetes and cardiovascular disease. While the role of several organs including adipose tissue have been implicated ...

Recommended for you

Counting down to the new ampere

August 29, 2016

After it's all over, your lights will be just as bright, and your refrigerator just as cold. But very soon the ampere—the SI base unit of electrical current—will take on an entirely new identity, and NIST scientists are ...

Hubble spots an irregular island in a sea of space

August 29, 2016

This image, courtesy of the NASA/ESA Hubble Space Telescope's Advanced Camera for Surveys (ACS), captures the glow of distant stars within NGC 5264, a dwarf galaxy located just over 15 million light-years away in the constellation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.